FASN and cancer: Schrijver et al. showed that the levels of FASN and ACACA were abnormally elevated in many human carcinomas and preneoplastic lesions, and the two proteins were closely related to aggressive cancer phenotypes and poor prognosis, revealing the therapeutic potential of the inhibition of the two proteins [72].